Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.

about

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.

Item

http://www.wikidata.org/entity/Q51741193

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Molecular iodine/doxorubicin n ...... fect in canine mammary cancer.

@en

Molecular iodine/doxorubicin n ...... fect in canine mammary cancer.

@nl

type

Item

label

Molecular iodine/doxorubicin n ...... fect in canine mammary cancer.

@en

Molecular iodine/doxorubicin n ...... fect in canine mammary cancer.

@nl

prefLabel

Molecular iodine/doxorubicin n ...... fect in canine mammary cancer.

@en

Molecular iodine/doxorubicin n ...... fect in canine mammary cancer.

@nl

P1476

Molecular iodine/doxorubicin n ...... ffect in canine mammary cancer

@en

P2093

Andrés A Dueñas-Bocanegra

http://www.w3.org/2001/XMLSchema#string

Benjamín Solorio-Perusquia

http://www.w3.org/2001/XMLSchema#string

Brenda Anguiano

http://www.w3.org/2001/XMLSchema#string

Brianda Landaverde-Quiroz

http://www.w3.org/2001/XMLSchema#string

Evangelina Delgado-González

http://www.w3.org/2001/XMLSchema#string

Gerardo Hernández-Alberto

http://www.w3.org/2001/XMLSchema#string

Laura Pérez-Guerrero

http://www.w3.org/2001/XMLSchema#string

Manuel Trejo-Mandujano

http://www.w3.org/2001/XMLSchema#string

Marco A De Paz-Campos

http://www.w3.org/2001/XMLSchema#string

Xóchitl Zambrano-Estrada

http://www.w3.org/2001/XMLSchema#string

P2860

Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy

The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues

Assessment of Japanese iodine intake based on seaweed consumption in Japan: A literature-based analysis

Use of potassium iodide in dermatology: updates on an old drug

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition

Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity.

Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excis

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone.

Antiproliferative/cytotoxic effects of molecular iodine, povidone-iodine and Lugol's solution in different human carcinoma cell lines.

P2888

s12917-018-1411-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12917-018-1411-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carmen Aceves

P577

2018-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101507555

http://www.w3.org/2001/XMLSchema#string

P698

29530037

http://www.w3.org/2001/XMLSchema#string

P932

5848438

http://www.w3.org/2001/XMLSchema#string